Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ: AYTU )

1.380 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 1.380
Bid (Size) 1.340 (1)
Ask (Size) 2.190 (2)
Prev. Close 1.380
Today's Range 1.380 - 1.380
52wk Range 1.300 - 3.447
Shares Outstanding 5,567,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results
Via ACCESS Newswire
Earnings Scheduled For February 12, 2025
Via Benzinga

Performance

YTD
-18.92%
-18.92%
1 Month
-17.86%
-17.86%
3 Month
-8.50%
-8.50%
6 Month
-44.13%
-44.13%
1 Year
-54.15%
-54.15%

More News

Read More
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Via ACCESSWIRE
Aytu BioPharma Disclosure Notification
Via ACCESSWIRE
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
Via ACCESSWIRE
Earnings Scheduled For November 13, 2024
Via Benzinga
Aytu BioPharma's Earnings: A Preview
Via Benzinga
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
Via ACCESSWIRE
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
Via ACCESSWIRE
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
Via ACCESSWIRE
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
Via ACCESSWIRE
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
Via ACCESSWIRE
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
Via ACCESSWIRE
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
Via ACCESSWIRE
Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
Via ACCESSWIRE
Sidoti Events, LLC's Virtual August Micro-Cap Conference
Via ACCESSWIRE
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
Via ACCESSWIRE
Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024
Via Newsfile
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Via ACCESSWIRE
AYTU Stock Earnings: Aytu BioPharma Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.